Page
%P
-
Article
Open Access5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2
Newborn screening for 5qSMA offers the potential for early, ideally pre-symptomatic, therapeutic intervention. However, limited data exist on the outcomes of individuals with 4 copies of SMN2, and there is no con...
-
Article
Open AccessGenotypes and phenotypes of patients with Lafora disease living in Germany
Lafora progressive myoclonus epilepsy (Lafora disease) is a rare, usually childhood-onset, fatal neurodegenerative disease caused by biallelic mutations in EPM2A (Laforin) or EPM2B (NHLRC1; Malin). The epidemiolo...